Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Taro Pharm Inds (TARO)

100.14 -0.55 (-0.55%)

02-22 16:01

Open:

100.5

Pre. Close:

100.69

High:

102.32

Low:

99.16

Volume:

55,619

Market Cap:

4016M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

102.365 - 102.759

102.759 - 103.211

Low:

98.571 - 98.993

98.993 - 99.478

Close:

100.182 - 100.862

100.862 - 101.643

Technical analysis  (as of: 2018-02-22 5:02:45 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 126.76     One year: 148.06

Support:

Support1: 98.94    Support2: 93.01

Resistance:

Resistance1: 108.53    Resistance2: 126.76

Pivot:

99.86

Moving Averages:

MA(5): 101.06     MA(20): 100.77

MA(100): 107.28     MA(250): 109.93

MACD:

MACD(12,26): -1.05     Signal(12,26,9): -1.38

%K %D:

%K(14,3): 60.50     %D(3): 62.42

RSI:

RSI(14): 48.48

52-Week:

High: 128.46  Low: 93.01  Change(%): -13.4

Average Vol(K):

3-Month: 12910  10-Days 9086

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
TARO has closed below upper band by 37.1%. Bollinger Bands are 4.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 08 Nov 2017 17:15:00 GMT
Taro Pharmaceutical Industries' (TARO) CEO Uday Vijaykumar Baldota on Q2 2018 ...

Tue, 13 Jun 2017 14:56:07 GMT
Taro Pharmaceuticals: Positioning To Negotiate With Dilip Shanghvi

Tue, 23 May 2017 18:22:30 GMT
Taro Pharmaceutical Industries' (TARO) Interim CEO Abhay Gandhi on Q4 2017 ...

Fri, 04 Aug 2017 16:03:49 GMT
Taro Pharmaceutical: Solid Cash-Rich Business With No Debt And A Catalyst

Fri, 09 Jun 2017 06:20:15 GMT
The Long Case For Taro Pharmaceutical

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

40.10

Shares Float (M)

40.10

% Held by Insiders

% Held by Institutions

12.40

Shares Short (K)

928

Shares Short Prior Month (K)

1640

Stock Financials

EPS

5.270

EPS Est. Current Year

9.490

EPS Est. Next Year

7.990

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

1.850

PEG Ratio

Profit Margin

29.97

Operating Margin

48.58

Return on Assets (ttm)

8.3

Return on Equity (ttm)

9.3

Qtrly Rev. Growth

-29.5

Gross Profit (p.s.)

13.785

Sales Per Share

EBITDA (p.s.)

11.431

Qtrly Earnings Growth

-87.10

Operating Cash Flow (M)

342.88

Levered Free Cash Flow (M)

326.02

atoplab.com

Valuation

P/E

19.16

P/E Growth Ratio

P/BV

54.58

P/S

239296512.00

P/CF

11.81

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.